Overview
This event is the kick-off for a Roche-hosted series of Symposia, dedicated to Neurology, The NeuRo Symposium will host speakers and leading customers in the field of Neuroscience from across the world and facilitate exchange among the participants. Roche aims to leveraging the momentum built via break-throughs in diagnostics and therapies in Alzheimer's disease as well as other neurological conditions such as traumatic brain injury and multiple sclerosis to foster vivid exchanges on key topics between renowned experts and interested customers.
Agenda
13th March, 2026 Novotel Barcelona City, Spain
9:00 - 9:15 (15 mins) - Welcome and Introduction
9:15 - 10:00 (45 mins) - Patient perspective
- Peter Berry & Deb Bunt (United Kingdom)
10:00 - 10:30 (30 mins) - Break
10:30 - 12:30 (120 mins) - Clinical utility - implementation
- Craig Ritchie(United Kingdom)
From Clinical Trials to Population Health: Scaling AD Detection - Kristian Frederksen (Denmark)
Integrating BBMs into Clinical Workflows: A European Perspective - Mari DeMarco (Canada)
Plasma Biomarker Reality Check: Data That Drove Implementation Decisions - Chris Rowe (Australia)
Utility of Blood Biomarkers: compared to PET and CSF in different care settings
12:30 -13:30 (60 mins) - Lunch
13:30 - 15:30 (120 mins) - Clinical & technical performance
- Henrik Zetterberg (Sweden)
From Proteins to Pathology: Evaluating the Utility of Tau Biomarkers in AD. - Marc Suarez (Spain)
A plasma biomarker panel: for detecting early amyloid-β accumulation in cognitively unimpaired individuals at risk for Alzheimer’s disease - Alicia Algeciras (United States)
Clinical and Analytical Performance of pTau 217:The Mayo Clinic Post-Launch Experience - Giovanni Frisoni (Switzerland)
Blood biomarkers in prevention: patient journeys In Alzheimer’s Disease?
15:30 - 16:00 (30 mins) - Break
- Sharmilee Gnanapavan (United Kingdom)
Beyond the Raw Number: Personalized care in MS using NfL - Marc Suarez (Spain) & Henrik Zetterberg(Sweden)
Unleashing the power of the Neuro Tool Kit - Alfonso Lagares (Spain)
From ER to ICU: S100’s Role in TBI Decision Pathways
An expert Perspective on the Biomarker Panel
18:00 (end) - Closing & Dinner
Meet the speakers
Engage in scientific and practical topics with experts in Neuroscience, covering Alzheimer's disease, traumatic brain injury, multiple sclerosis and Parkinson's disease.
